SOHM Inc (SHMN)

[hardlesson]

These are the Professionals at the $SHMN helm:

In no particular order...They can bring it home, imo.

Mark Stevens, Science Advisor:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174197635
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174136261
https://www.linkedin.com/in/mark-stevens-phd-810167a/

Eddie Chung, Coastar CEO:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174150084
"This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."
https://coastartherapeutics.com/about-us/
https://www.globenewswire.com/news-release/2024/04/01/2855240/0/en/SOHM-Inc-and-Coastar-Therapeutics-Sign-MoU-and-Announce-Collaboration-to-Revolutionize-Genome-Editing-Using-Red-Blood-Cell-Membrane-Derived-Carriers.html

Tony Tontat, Strategic Financial Analyst:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173733984
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173582848
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173546689

Alfred Gallegos, SHMN Research Scientist:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660637
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660026
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173659156
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Collaborates-with-University-of-Arizona-Center-for-Innovation-to-Advance-ABBIE-a-Groundbreaking-Non-Viral-Gene-Edit?id=416912


Eric Furman, Ph.D. Knobbe Martens Sohm Intellectual Property Attorney:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173289185
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173246026

Wm. Dewey Rushing, VP of Quality Sohm:
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082914
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082680
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173031688
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172828177
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172794328
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-as-VP-of-Quality-with-Immediate-Effect?id=413696
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-former-US-FDA-Investigator-to-its-Advisory-Board?id=344969

Dr. Krishna Bhatt, Chief Medical Advisor, Bioscientist and Cardiologist:
Current owner of 82 Million Common shares, and recent Preferred Shares in exchange for Funding.
https://www.otcmarkets.com/otcapi/company/financial-report/396087/content
https://www.biomedwire.com/leadership-changes-at-sohm-inc-shmn-to-strengthen-growth-strategies-for-generic-drug-market-and-gene-editing-platform-development/
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Its-Advisory-Board-Appointing-Dr-Krishna-Bhat-MD-PhD-FACC-as-Chief-Medical-Advisor?id=411792

Dr. David Aguilar, Sohm Chief Operating Officer:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172703663
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172599661
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announce-the-Appointment-of-Dr-David-Aguilar-PhD-as-a-Chief-Operating-Officer-with-the-Company-with-Immediate-E?id=410079
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Advisory-Board-with-Appointment-of-Dr-David-Aguilar-PhD-as-its-Expert-Medical-Advisor?id=346149

We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj

— SOHM, Inc. (@sohminc) April 9, 2024

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

After a successful visit to Japan, our COO, Dr. David Aguilar is back and here are couple pictures of him working at Carlsbad facility with production in-charge.

Secondly, we are glad to share that we are working with multiple companies for CDMO services and production at the… pic.twitter.com/Wj5qUGgpRe

— SOHM, Inc. (@sohminc) January 25, 2024

Baron Night, CEO:

We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs

— SOHM, Inc. (@sohminc) December 31, 2023

_____
More could be said, but I like the new SHMN. Baby Pharma at .0013.
hL